Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Alto Neuroscience Q2 EPS $(0.65) Misses $(0.61) Estimate

Author: Benzinga Newsdesk | August 13, 2025 03:25pm
Alto Neuroscience (NYSE:ANRO) reported quarterly losses of $(0.65) per share which missed the analyst consensus estimate of $(0.61) by 7.08 percent. This is a 8.33 percent decrease over losses of $(0.60) per share from the same period last year.

Posted In: ANRO


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist